
Marc Porter describes how his group’s surface science work led to SERS-based immunoassays, why reproducibility and pre-analytics decide whether a test reaches the clinic, and the questions he still wants to answer.
Click the title above to open the Spectroscopy June 2009 regular issue, Vol 24 No 6, in an interactive PDF format.
over 17 years ago
Statistics and Chemometrics for Clinical Data Reporting, Part Iover 17 years ago
Market Profile: Raman-Enabled FT-IRover 17 years ago
Understanding and Interpreting the New GAMP 5 Software Categoriesover 17 years ago
Product Resourcesover 17 years ago
Auger Spectroscopy



